Presentation topics range from breast cancer to SurVaxM cancer immunotherapy to CAR-T clinical trial access
Clinical researchers from Roswell Park Comprehensive Cancer Center are among the experts invited to share insights and clinical best practices at the National Comprehensive Cancer Network (NCCN) 2026 Annual Conference March 27-29 in Orlando, Florida. Roswell Park is a longtime member of the NCCN.
Among those speaking during the meeting will be Reem Dergham, MD, of the Department of Medicine, who will give an invited talk as part of the “Oral Presentations from Top Poster Presenters” session on Friday, March 27, at 4:15 p.m. ET, detailing findings from an early-stage clinical trial of SurVaxM, an immunotherapy developed at Roswell Park, in patients with neuroendocrine tumors (NETs), and Jessica Young, MD, FACS, one of three expert panelists on the Breast Cancer Case Review session on Sunday, March 29, at 9:15 a.m. ET. Both talks will take place at the Caribe Royale Orlando and will be available online for registered attendees.
Andrew Storer, PhD, DNP, RN, NP-C, FAANP, Chief Nursing Officer, will speak at an affiliated NCCN Best Practices Committee event, the Operational Excellence in Cancer Care Program, focused on redesigning care delivery.
"I’m honored to join NCCN colleagues to share how we’re redesigning care delivery to better support patients and care teams,” says Dr. Storer, pictured above. “Advancing more efficient, patient?centered systems is core to our mission at Roswell Park."
Other Roswell Park team members presenting new research at the conference:
- Vaishali Deenadayalan, MD, with senior author Bailey Gleason Fitzgerald, MD — Impact of Embedded Thoracic Oncology Nurse Coordinators on Goals of Care Documentation
- Amy Gallagher, PsyD, MSHCT, with senior author Amy Case, MD, FAAHPM — Changing Environment & Culture at a Comprehensive Cancer Center
- Fayaz Khan, MD, co-first author — Endothelial Activation and Stress Index Scores as Predictors of Outcomes After Chimeric Antigen Receptor T-cell (CAR T) Therapy
- Shaniza Haniff, MBBS, MPH — Machine Learning Models Predict Depression Among Pancreatic and Head and Neck Cancer Patients
- Mohammad Zia, PhD, with senior author Mukund Seshadri, DDS, PhD — nSIGHT: A Research Discovery Platform for Visualization, Integration and Retrospective Analysis of Multimodal Clinical Data
- Reem Dergham, MD, with senior author Jasmeet Kaur, MD — Clinical Outcomes of Gastric Outlet Obstruction Among Patients with Pancreatic Cancer Stratified by Sex: A Multicenter Analysis
- Zunairah Shah, MD, with senior author Sheheryar Kabraji, MD — Validating an LLM for Detecting Enrollment Disparities in Breast Cancer Trials
- Jayasree Krishnan, MD, MSPH, with senior author Kannan Thanikachalam, MD — Comparative Survival in Elderly Colon Cancer Patients Treated with Adjuvant CAPOX/FOLFOX Versus 5-FU/Capecitabine
- Rahul Kumar Thakur, MD — Access to CAR-T and CD3-Bispecific T-Cell Engager Clinical Trials in the United States